Blog
Stocks in Scope
Portfolio
Covered Call
More...
Log In
Gilead
Dividend
Options
Valuation
Valuation and Other Thoughts
10/28/2020: GILD report a beat in both revenue and earnings. Remdesivir brings in $873 million in the quarter. Stock down recently; very good value in my opinion. But into the sellers!!!
Pick - BUY.